These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16998588)

  • 1. Transcription factor MITF regulates cardiac growth and hypertrophy.
    Tshori S; Gilon D; Beeri R; Nechushtan H; Kaluzhny D; Pikarsky E; Razin E
    J Clin Invest; 2006 Oct; 116(10):2673-81. PubMed ID: 16998588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Identification and differential expression of the microphthalmia-associated transcription factor in heart and isolated cardiomyocytes from Guinea pigs: possible role in hypertrophy and viability].
    Gunturiz ML; Gómez LA
    Biomedica; 2014; 34(3):387-402. PubMed ID: 25504126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD38 promotes angiotensin II-induced cardiac hypertrophy.
    Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
    J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.
    Mehta G; Kumarasamy S; Wu J; Walsh A; Liu L; Williams K; Joe B; de la Serna IL
    J Mol Cell Cardiol; 2015 Nov; 88():101-10. PubMed ID: 26388265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FHL2 switches MITF from activator to repressor of Erbin expression during cardiac hypertrophy.
    Rachmin I; Amsalem E; Golomb E; Beeri R; Gilon D; Fang P; Nechushtan H; Kay G; Guo M; Yiqing PL; Foo RS; Fisher DE; Razin E; Tshori S
    Int J Cardiol; 2015 Sep; 195():85-94. PubMed ID: 26025865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between the E2F pathway and β-adrenergic signaling in the pathological hypertrophic response of myocardium.
    Major JL; Salih M; Tuana BS
    J Mol Cell Cardiol; 2015 Jul; 84():179-90. PubMed ID: 25944088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes.
    Morisco C; Marrone C; Galeotti J; Shao D; Vatner DE; Vatner SF; Sadoshima J
    Cardiovasc Res; 2008 Apr; 78(1):36-44. PubMed ID: 18194989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annexin A7 deficiency potentiates cardiac NFAT activity promoting hypertrophic signaling.
    Voelkl J; Alesutan I; Pakladok T; Viereck R; Feger M; Mia S; Schönberger T; Noegel AA; Gawaz M; Lang F
    Biochem Biophys Res Commun; 2014 Feb; 445(1):244-9. PubMed ID: 24508799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy.
    Kuzman JA; O'Connell TD; Gerdes AM
    Endocrinology; 2007 Jul; 148(7):3477-84. PubMed ID: 17395699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
    Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
    Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.
    Murakami M; Ikeda T; Saito T; Ogawa K; Nishino Y; Nakaya K; Funaba M
    Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.
    He S; Li CG; Slobbe L; Glover A; Marshall E; Baguley BC; Eccles MR
    Melanoma Res; 2011 Feb; 21(1):24-34. PubMed ID: 21164369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
    Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A
    Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
    Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
    Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy.
    Kim J; Wende AR; Sena S; Theobald HA; Soto J; Sloan C; Wayment BE; Litwin SE; Holzenberger M; LeRoith D; Abel ED
    Mol Endocrinol; 2008 Nov; 22(11):2531-43. PubMed ID: 18801929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction.
    Ulm S; Liu W; Zi M; Tsui H; Chowdhury SK; Endo S; Satoh Y; Prehar S; Wang R; Cartwright EJ; Wang X
    J Mol Cell Cardiol; 2014 Jul; 72(100):104-16. PubMed ID: 24631771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity.
    Yoshida T; Yamashita M; Horimai C; Hayashi M
    J Biol Chem; 2014 Sep; 289(38):26107-26118. PubMed ID: 25100730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Effects of Attenuating Gsα - Dependent Signaling.
    Streit MR; Weiss CS; Meyer S; Ochs MM; Hagenmueller M; Riffel JH; Buss SJ; Heger T; Katus HA; Hardt SE
    PLoS One; 2016; 11(1):e0146988. PubMed ID: 26811901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pax3 target gene recognition occurs through distinct modes that are differentially affected by disease-associated mutations.
    Corry GN; Underhill DA
    Pigment Cell Res; 2005 Dec; 18(6):427-38. PubMed ID: 16280008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.